Core Viewpoint - Aemetis, Inc. has signed a $30 million EPC contract with NPL Construction Co. to install a Mechanical Vapor Recompression system at its Keyes ethanol plant, which is expected to significantly enhance energy efficiency and financial performance [1][2][3]. Financial Summary - For the three months ended May 31, 2024, Aemetis reported a net income of $330.837 million, a substantial increase from $53.406 million in the same period of 2023 [1]. - Cash flows from operating activities decreased to $327.964 million from $828.092 million year-over-year [1]. - The company experienced a net cash outflow from investing activities of $60.743 million, compared to a net inflow of $111.646 million in the previous year [1]. Project Details - The MVR project has secured approximately $19.7 million in tax credits and grants from various governmental bodies, including the IRS and California Energy Commission [2]. - The MVR system is projected to reduce natural gas usage at the Keyes plant by about 80%, leading to an estimated $32 million in annual cash flow from energy savings [3]. Strategic Impact - The MVR project is part of Aemetis' strategy to enhance operational margins and cash flow while supporting California's clean energy goals [4][5]. - The project aligns with regulatory trends, including rising LCFS credit prices and the anticipated adoption of E15 ethanol blends in California [5].

Core Insights - Aemetis, Inc. is entering a high-growth phase with its Dairy RNG platform, supported by regulatory approvals and capacity expansion [1][3] - The company generated $3.1 million in revenue from 106,400 MMBtu of RNG produced by eleven digesters in Q2 2025 [1][5] - CARB approved seven new LCFS pathways with a blended CI score of -384, increasing LCFS credit value by approximately 120% [1][5] - Capacity is projected to reach 550,000 MMBtu by year-end 2025 and further increase to 1.0 million MMBtu by the end of 2026 [1][5] Financial Developments - Aemetis secured $83 million in Section 48 investment tax credit sales, translating to around $70 million in cash [5] - The company has obtained 20-year USDA-guaranteed financing, with Section 45Z monetization expected to start in Q3 2025 as a recurring revenue stream [5] Project Advancements - Aemetis is advancing a $30 million MVR project at its California Ethanol plant, aiming to reduce natural gas usage by 80% and generate approximately $32 million in annual cash flow starting in 2026 [5] - The company's subsidiary in India is targeting an IPO in early 2026 [5]

Financial Data and Key Metrics Changes - Revenues for Q2 2025 were $52.2 million, an increase of $9.3 million from Q1 2025, primarily due to biodiesel orders in India [4] - Operating loss improved by $4.9 million compared to Q2 2024, reflecting reduced selling, general and administrative expenses [5] - Net loss was $23.4 million, roughly flat compared to Q2 2024 after adjusting for nonrecurring charges [5] - Cash at year-end was $1.6 million following $3.6 million of investment in carbon intensity reduction and dairy renewable natural gas production expansion [6] Business Line Data and Key Metrics Changes - California Dairy Renewable Natural Gas recognized $3.1 million in revenue from 11 operating digesters during Q2 2025 [5] - Ethanol production in California decreased to 13.8 million gallons to maximize margins, but production was recently increased to meet market demand [11] - Biodiesel deliveries to Indian government oil marketing companies resumed in April, generating $11.9 million in revenue during Q2 2025 [12] Market Data and Key Metrics Changes - LCFS credit prices increased from about $42 to approximately $60 in the past month, with a current cap of $268 for 2025 [10] - The California Air Resources Board (CARB) approved seven dairy pathways with a blended negative carbon intensity score, unlocking 120% more LCFS credit revenue [8] - The U.S. ethanol market could expand by over 5 billion gallons per year if E15 gasoline is approved in all states, significantly impacting demand [19] Company Strategy and Development Direction - The company is focused on scaling up renewable natural gas production, targeting a capacity of 550,000 MMBtu this year and 1,000,000 MMBtu by 2026 [7] - Aemetis is actively pursuing an IPO for its India subsidiary in early 2026, with plans to expand into ethanol production supported by government policies [12] - The company is working on refinancing efforts to improve its capital structure and reduce debt [6][54] Management's Comments on Operating Environment and Future Outlook - Management expects multiple revenue streams from India, LCFS credits, and federal tax incentives to ramp up as the year progresses, positioning the company for a stronger 2025 [6] - The company anticipates that the amendments to the LCFS program will lead to increased credit prices and a tightening supply, benefiting its operations [15] - Management expressed optimism about the growth of the biofuels and biogas industries due to supportive federal and state policies [14][20] Other Important Information - The company has received $20 million in grants and tax credits to fund a mechanical vapor recompression system expected to add $32 million in annual cash flow starting in 2026 [11] - Aemetis has sold $83 million in investment tax credits related to its RNG facilities, receiving approximately $70 million in cash [9] Q&A Session Summary Question: Impact of CARB approval on EBITDA - Management confirmed that seven dairies are approved, with four more pending, and the financial impact is correlated with LCFS credit prices [23][25] Question: D3 RINs demand outlook - Management noted that there is a universal opinion that D3 RINs are being understated and emphasized the importance of the renewable fuel standard [27][28] Question: Update on 45Z tax credits - Management indicated that updates to the GREET model could allow for the generation of 45Z credits soon, with expectations for significant revenue from these credits [34][36] Question: Monetization strategy for production tax credits - Management expects 45Z credits to become a recurring quarterly revenue item, with catch-up revenue anticipated in Q3 2025 [48] Question: Progress on India IPO - Management confirmed that the new CFO is on board and the process is underway, with public filing documents expected this fall [50][51] Question: Refinancing process status - Management stated they are deep into the refinancing process, with expectations to complete due diligence and documentation by August [64][66]

Group 1: Earnings Performance - Aemetis reported a quarterly loss of $0.41 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.35, representing an earnings surprise of -17.14% [1] - The company posted revenues of $52.24 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 35.62%, compared to year-ago revenues of $66.56 million [2] - Over the last four quarters, Aemetis has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Group 2: Stock Performance and Outlook - Aemetis shares have lost about 4.5% since the beginning of the year, while the S&P 500 has gained 7.9% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is -$0.26 on revenues of $104.19 million, and -$1.34 on revenues of $332.8 million for the current fiscal year [7] Group 3: Industry Context - The Biofuels industry, to which Aemetis belongs, is currently in the top 41% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Aemetis' stock performance [5][6]

PART I [Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements.) Aemetis, Inc.'s Q2 2025 unaudited financials reflect decreased assets, increased current liabilities from debt reclassification, an improved net loss, and a 'going concern' warning due to significant debt and lender reliance [Consolidated Condensed Balance Sheets](index=4&type=section&id=CONSOLIDATED%20CONDENSED%20BALANCE%20SHEETS) As of June 30, 2025, total assets were $240.0 million, a decrease from $259.3 million at year-end 2024, with current liabilities sharply rising to $321.9 million from $144.0 million due to debt reclassification, worsening the total stockholders' deficit to $289.3 million Consolidated Balance Sheet Highlights (in thousands) | Balance Sheet Item | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Current Assets** | $20,086 | $44,696 | | **Total Assets** | $240,016 | $259,302 | | **Total Current Liabilities** | $321,927 | $143,968 | | **Total Liabilities** | $529,271 | $523,230 | | **Total Stockholders' Deficit** | $(289,255) | $(263,928) | [Consolidated Condensed Statements of Operations](index=5&type=section&id=CONSOLIDATED%20CONDENSED%20STATEMENTS%20OF%20OPERATIONS%20AND%20COMPREHENSIVE%20INCOME%20(LOSS)) For the three months ended June 30, 2025, revenues decreased to $52.2 million from $66.6 million year-over-year, resulting in a worsening gross loss of $3.4 million, though the net loss improved to $23.4 million, or ($0.41) per share, primarily due to lower SG&A expenses Q2 2025 vs Q2 2024 Performance (in thousands, except per share data) | Metric | Q2 2025 | Q2 2024 | | :--- | :--- | :--- | | **Revenues** | $52,243 | $66,561 | | **Gross Loss** | $(3,355) | $(1,806) | | **Operating Loss** | $(10,674) | $(13,606) | | **Net Loss** | $(23,395) | $(29,174) | | **Net Loss Per Share (Basic)** | $(0.41) | $(0.66) | Six Months 2025 vs 2024 Performance (in thousands, except per share data) | Metric | H1 2025 | H1 2024 | | :--- | :--- | :--- | | **Revenues** | $95,129 | $139,195 | | **Gross Loss** | $(8,435) | $(2,418) | | **Operating Loss** | $(26,229) | $(23,068) | | **Net Loss** | $(47,924) | $(53,405) | | **Net Loss Per Share (Basic)** | $(0.87) | $(1.24) | [Consolidated Condensed Statements of Cash Flows](index=6&type=section&id=CONSOLIDATED%20CONDENSED%20STATEMENTS%20OF%20CASH%20FLOWS) For the six months ended June 30, 2025, net cash used in operating activities significantly improved to $5.6 million, while net cash provided by financing activities was $11.3 million, primarily from stock sales and new borrowings, leading to an overall increase of $0.8 million in cash and cash equivalents Six-Month Cash Flow Summary (in thousands) | Cash Flow Activity | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | **Net Cash Used in Operating Activities** | $(5,577) | $(15,372) | | **Net Cash Used in Investing Activities** | $(4,939) | $(5,935) | | **Net Cash Provided by Financing Activities** | $11,268 | $18,743 | | **Net Change in Cash** | $759 | $(2,538) | [Notes to Consolidated Condensed Financial Statements](index=8&type=section&id=Notes%20to%20Consolidated%20Condensed%20Financial%20Statements) The notes detail the company's operational segments, accounting policies, and financial position, including significant debt obligations and a critical disclosure on liquidity and going concern, highlighting substantial operational and financial risks - The company operates in three main segments: California Ethanol, California Dairy Renewable Natural Gas (RNG), and India Biodiesel, while also developing projects in Sustainable Aviation Fuel (SAF), Renewable Diesel (RD), and Carbon Capture and Underground Sequestration (CCUS)[25](index=25&type=chunk)[26](index=26&type=chunk)[27](index=27&type=chunk) - Total debt stood at **$344.2 million** as of June 30, 2025, with a significant portion of **$270.6 million** due within the next twelve months, highlighting near-term refinancing risk[45](index=45&type=chunk)[58](index=58&type=chunk) - The company has concluded that there is substantial doubt about its ability to continue as a going concern due to its significant debt, reliance on its senior lender, and expected near-term cash flow shortfalls[112](index=112&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=33&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations.) Management discusses a **21.5% decrease** in Q2 2025 revenue, primarily from India Biodiesel, offset by strong California Dairy RNG growth, while liquidity remains a critical concern due to debt and lender reliance, despite outlined strategies for cash flow improvement - The company is focused on building a circular bioeconomy using agricultural products and waste to produce low-carbon renewable fuels[115](index=115&type=chunk) - Key strategic initiatives to improve liquidity include constructing a Mechanical Vapor Recompression (MVR) system to reduce natural gas use, building new dairy digesters for RNG production, and monetizing new Section 45Z tax credits for both ethanol and RNG[101](index=101&type=chunk)[105](index=105&type=chunk)[102](index=102&type=chunk) - Despite plans to improve liquidity, management reiterates that substantial doubt exists about the company's ability to continue as a going concern due to its debt levels and reliance on its senior lender[112](index=112&type=chunk) [Results of Operations](index=35&type=section&id=Results%20of%20Operations) Comparing Q2 2025 to Q2 2024, total revenues fell by $14.3 million (**21.5%**) to $52.2 million, driven by a $12.9 million decrease in India Biodiesel sales, while California Dairy RNG revenue grew by $1.5 million (**90.9%**), and the total gross loss increased to $3.4 million Revenues by Segment - Q2 2025 vs Q2 2024 (in thousands) | Segment | Q2 2025 | Q2 2024 | Change (%) | | :--- | :--- | :--- | :--- | | California Ethanol | $37,288 | $40,132 | (7.1)% | | California Dairy RNG | $3,051 | $1,598 | 90.9% | | India Biodiesel | $11,904 | $24,831 | (52.1)% | | **Total** | **$52,243** | **$66,561** | **(21.5)%** | Gross Profit (Loss) by Segment - Q2 2025 vs Q2 2024 (in thousands) | Segment | Q2 2025 | Q2 2024 | Change (%) | | :--- | :--- | :--- | :--- | | California Ethanol | $(3,806) | $(3,921) | (2.9)% | | California Dairy RNG | $855 | $(136) | (728.7)% | | India Biodiesel | $(404) | $2,251 | (117.9)% | | **Total** | **$(3,355)** | **$(1,806)** | **85.8%** | - The decrease in SG&A expense was primarily due to a one-time **$3.6 million** loss on an asset write-off in Q2 2024, which was not repeated in Q2 2025[140](index=140&type=chunk) [Liquidity and Capital Resources](index=39&type=section&id=Liquidity%20and%20Capital%20Resources) The company's liquidity position is precarious, with cash and cash equivalents at only $1.6 million and a current ratio of 0.06 as of June 30, 2025, relying heavily on equity sales and debt, including **$225.7 million** with its senior lender, Third Eye Capital, with significant maturities in 2026 - Cash and cash equivalents were **$1.6 million** at June 30, 2025, with a current ratio of **0.06**, indicating severe short-term liquidity pressure[152](index=152&type=chunk) - The company is highly dependent on its senior lender, Third Eye Capital, for continued financing and amendments to its debt facilities, with debt totaling **$225.7 million** as of June 30, 2025, including **$45.6 million** due on demand and **$152.4 million** due in April 2026[157](index=157&type=chunk)[159](index=159&type=chunk) - During the six months ended June 30, 2025, the company sold **10.0 million** shares of common stock for net proceeds of **$18.0 million** through its at-the-market offering[164](index=164&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=42&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk.) This item is marked as 'Not applicable' in the report, indicating no new or materially changed information to disclose regarding market risk compared to the last annual report - The company has indicated that this section is not applicable for this reporting period[168](index=168&type=chunk) [Controls and Procedures](index=42&type=section&id=Item%204.%20Controls%20and%20Procedures.) Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were not effective as of June 30, 2025, due to previously identified material weaknesses in IT general controls and financial reporting systems, with remediation plans currently in progress - The CEO and CFO concluded that disclosure controls and procedures were not effective as of the end of the period[169](index=169&type=chunk) - The ineffectiveness is due to material weaknesses related to IT general controls and financial reporting systems, as identified in the 2024 Form 10-K[169](index=169&type=chunk)[171](index=171&type=chunk) - Remediation plans to address the material weaknesses are in progress[171](index=171&type=chunk) PART II [Legal Proceedings](index=44&type=section&id=Item%201.%20Legal%20Proceedings.) The company reported no legal proceedings for the period - None reported[172](index=172&type=chunk) [Risk Factors](index=44&type=section&id=Item%201A.%20Risk%20Factors.) This item is marked as 'Not applicable,' indicating no material changes from the risk factors previously disclosed in the company's Annual Report on Form 10-K - Not applicable[173](index=173&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=44&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds.) During the second quarter of 2025, the company issued warrants to two subordinated lenders to purchase **113,000 shares** of common stock at $0.01 per share in connection with debt extensions, and also issued **29,240 shares** to a vendor for services, with these issuances exempt from registration under Section 4(2) of the Securities Act of 1933 - Issued warrants to purchase **113,000 shares** to subordinated lenders as part of debt extension agreements[174](index=174&type=chunk) - Issued **29,240 shares** of common stock to a vendor for services[175](index=175&type=chunk) [Defaults Upon Senior Securities](index=44&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities.) The company reported no unresolved defaults on its senior securities during the six months ended June 30, 2025 - No unresolved defaults on senior securities occurred during the period[176](index=176&type=chunk) [Signatures](index=46&type=section&id=Signatures) - The report was signed on August 7, 2025, by Eric A. McAfee, Chairman and CEO, and Todd A. Waltz, Executive Vice President and CFO[183](index=183&type=chunk)

[Financial and Operational Highlights](index=1&type=section&id=Financial%20and%20Operational%20Highlights) Aemetis reported increased Q2 2025 revenue to $52.2 million, driven by India biodiesel and Dairy RNG, alongside strategic biogas and India IPO preparations Q2 2025 Key Financial Metrics | Metric | Value ($) | Note | | :--- | :--- | :--- | | **Revenues** | $52.2M | Increased $9.3M from Q1 2025 | | **Aemetis Biogas Revenue** | $3.1M | From 11 operating digesters | | **Operating Loss** | Improved by $4.9M | Compared to Q1 2025, due to lower SG&A | - The increase in revenue was primarily driven by the California Ethanol and Dairy RNG segments, along with new orders for the India Biodiesel business from Oil Marketing Companies[3](index=3&type=chunk)[5](index=5&type=chunk) - Strategic developments include the appointment of a new CFO for the India subsidiary, targeting a public listing in early **2026**[5](index=5&type=chunk) - Aemetis Biogas signed a **$27 million** agreement with NPL for H₂S and compression units for **15** dairy digesters and received CARB approval for **7** new LCFS pathways[5](index=5&type=chunk) - The company anticipates increased income and cash flow from Section 45Z production tax credits and cost reductions from the mechanical vapor recompression project in its California Ethanol segment[3](index=3&type=chunk)[4](index=4&type=chunk) [Financial Results](index=2&type=section&id=Financial%20Results) Aemetis reported Q2 2025 revenues of $52.2 million, a decrease from Q2 2024, but improved operating and net losses for both the quarter and first half [Financial Results for the Three Months Ended June 30, 2025](index=2&type=section&id=Financial%20Results%20for%20the%20Three%20Months%20Ended%20June%2030%2C%202025) Q2 2025 revenues decreased to $52.2 million year-over-year, while operating and net losses improved to $10.7 million and $23.4 million respectively, despite a wider gross loss Q2 2025 vs Q2 2024 Financial Comparison | Metric | Q2 2025 ($) | Q2 2024 ($) | Change ($) | | :--- | :--- | :--- | :--- | | **Revenues** | $52.2M | $66.6M | ($14.4M) | | **Gross Loss** | ($3.4M) | ($1.8M) | ($1.6M) | | **Operating Loss** | ($10.7M) | ($13.6M) | $2.9M Improvement | | **Net Loss** | ($23.4M) | ($29.2M) | $5.8M Improvement | - SG&A expenses decreased significantly to **$7.3 million** from **$11.8 million** year-over-year, primarily due to a one-time **$3.6 million** loss on asset disposals in 2024[7](index=7&type=chunk) - Cash at quarter-end was **$1.6 million**, up from **$900 thousand** at the end of 2024, with **$3.6 million** invested in capital projects during the quarter[10](index=10&type=chunk) [Financial Results for the Six Months Ended June 30, 2025](index=2&type=section&id=Financial%20Results%20for%20the%20Six%20Months%20Ended%20June%2030%2C%202025) H1 2025 revenues decreased to $95.1 million due to India contract delays, while gross and operating losses widened, but net loss improved to $47.9 million H1 2025 vs H1 2024 Financial Comparison | Metric | H1 2025 ($) | H1 2024 ($) | Change ($) | | :--- | :--- | :--- | :--- | | **Revenues** | $95.1M | $139.2M | ($44.1M) | | **Gross Loss** | ($8.4M) | ($2.4M) | ($6.0M) | | **Operating Loss** | ($26.2M) | ($23.1M) | ($3.1M) | | **Net Loss** | ($47.9M) | ($53.4M) | $5.5M Improvement | - The lower revenue in H1 2025 was primarily due to delays in receiving contracts from government-owned Oil Marketing Companies in India[11](index=11&type=chunk) - Total investments in capital projects during H1 2025 amounted to **$5.4 million**, with **$4.1 million** dedicated to Aemetis Biogas projects[14](index=14&type=chunk) [Company Overview and Forward-Looking Statements](index=2&type=section&id=Company%20Overview%20and%20Forward-Looking%20Statements) Aemetis is a renewable energy company producing RNG, fuels, and biochemicals, with operations in California and India, and developing SAF, while reporting non-GAAP measures and forward-looking statements - Aemetis operates a California biogas digester network (RNG), a **65 MGY** ethanol plant in California, an **80 MGY** biodiesel facility in India, and is developing a SAF/renewable diesel biorefinery[15](index=15&type=chunk)[16](index=16&type=chunk) - The company defines Adjusted EBITDA as net loss adjusted for interest, taxes, depreciation, amortization, accretion, and share-based compensation[17](index=17&type=chunk) - The release contains forward-looking statements regarding growth plans, market trends, project development, and capital raising, subject to various risks and uncertainties[19](index=19&type=chunk) [Consolidated Financial Statements](index=4&type=section&id=Consolidated%20Financial%20Statements) This section presents unaudited consolidated financial statements, detailing Q2 and H1 2025 operations, and the balance sheet as of June 30, 2025, showing asset and liability changes [Consolidated Condensed Statements of Operations](index=4&type=section&id=CONSOLIDATED%20CONDENSED%20STATEMENTS%20OF%20OPERATIONS) Aemetis reported a net loss of $23.4 million for Q2 2025 and $47.9 million for H1 2025, showing improvement compared to prior-year periods, with a Q2 2025 loss per share of $0.41 Consolidated Condensed Statements of Operations (unaudited, in thousands, except per share data) | | For the three months ended June 30, (in thousands) | For the six months ended June 30, (in thousands) | | :--- | :--- | :--- | :--- | :--- | | | **2025** | **2024** | **2025** | **2024** | | **Revenues** | $52,243 | $66,561 | $95,129 | $139,195 | | Cost of goods sold | 55,598 | 68,367 | 103,564 | 141,613 | | **Gross loss** | **(3,355)** | **(1,806)** | **(8,435)** | **(2,418)** | | SG&A expenses | 7,319 | 11,800 | 17,794 | 20,650 | | **Operating loss** | **(10,674)** | **(13,606)** | **(26,229)** | **(23,068)** | | Interest expense | 12,330 | 11,724 | 26,023 | 22,237 | | Accretion of Series A preferred units | 2,032 | 3,477 | 4,311 | 6,788 | | **Net loss** | **$(23,395)** | **$(29,174)** | **$(47,924)** | **$(53,405)** | | **Net loss per common share (Basic & Diluted)** | **$(0.41)** | **$(0.66)** | **$(0.87)** | **$(1.24)** | [Consolidated Condensed Balance Sheets](index=5&type=section&id=CONSOLIDATED%20CONDENSED%20BALANCE%20SHEETS) As of June 30, 2025, Aemetis reported total assets of $240.0 million, total liabilities of $529.3 million, and a stockholders' deficit of $289.3 million, with a notable increase in current long-term debt Consolidated Condensed Balance Sheets (in thousands) | | June 30, 2025 (Unaudited, in thousands) | December 31, 2024 (in thousands) | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $1,645 | $898 | | Total current assets | $20,086 | $44,696 | | Property, plant and equipment, net | $204,641 | $199,392 | | **Total assets** | **$240,016** | **$259,302** | | **Liabilities and Stockholders' Deficit** | | | | Current portion of long term debt | $247,615 | $63,745 | | Total current liabilities | $321,927 | $143,968 | | Total long term liabilities | $207,344 | $379,262 | | Total stockholders' deficit | $(289,255) | $(263,928) | | **Total liabilities and stockholders' deficit** | **$240,016** | **$259,302** | [Non-GAAP Reconciliation and Operational Metrics](index=6&type=section&id=Non-GAAP%20Reconciliation%20and%20Operational%20Metrics) This section presents non-GAAP Adjusted EBITDA reconciliation and operational metrics, showing a slight improvement in Q2 2025 Adjusted EBITDA loss and varied production volumes across segments [Reconciliation of Adjusted EBITDA to Net Income/(Loss)](index=6&type=section&id=RECONCILIATION%20OF%20ADJUSTED%20EBITDA%20TO%20NET%20INCOME%2F%28LOSS%29) Aemetis reported an Adjusted EBITDA loss of $5.8 million for Q2 2025, a slight improvement, but a $16.4 million loss for H1 2025, a deterioration, with reconciliation details provided Reconciliation of Adjusted EBITDA to Net Loss (unaudited, in thousands) | | For the three months ended June 30, (in thousands) | For the six months ended June 30, (in thousands) | | :--- | :--- | :--- | :--- | :--- | | | **2025** | **2024** | **2025** | **2024** | | **Net loss** | **$(23,395)** | **$(29,174)** | **$(47,924)** | **$(53,405)** | | Total adjustments | 17,627 | 23,268 | 31,494 | 42,749 | | **Adjusted EBITDA** | **$(5,768)** | **$(5,906)** | **$(16,430)** | **$(10,656)** | [Production and Price Performance](index=7&type=section&id=PRODUCTION%20AND%20PRICE%20PERFORMANCE) Q2 2025 production and sales varied by segment, with California Ethanol volumes decreasing, Dairy RNG increasing, and India Biodiesel sales significantly dropping due to contract delays Q2 2025 vs Q2 2024 Production and Sales Comparison | Segment | Metric | Q2 2025 (Units) | Q2 2024 (Units) | | :--- | :--- | :--- | :--- | | **California Ethanol** | Gallons sold (millions) | 13.8 | 14.8 | | **CA Dairy RNG** | MMBtu sold (thousands) | 106.4 | 88.0 | | **India Biodiesel** | Metric tons sold (thousands) | 9.4 | 20.4 | Q2 2025 vs Q2 2024 Average Price Comparison | Segment | Metric | Q2 2025 ($) | Q2 2024 ($) | | :--- | :--- | :--- | :--- | | **California Ethanol** | Avg. sales price/gallon | $2.01 | $1.99 | | **CA Dairy RNG** | Avg. price per MMBtu | $2.75 | $2.19 | | **India Biodiesel** | Avg. sales price/metric ton | $1,010 | $1,162 |

Core Viewpoint - Aemetis, Inc. will host a conference call on August 7, 2025, to review its second quarter 2025 financial results [3] Group 1: Conference Call Details - The conference call is scheduled for Thursday, August 7, 2025, at 11 am Pacific Time (PT) [3] - Participants can join the call using a toll-free number or an international dial-in option, with an entry code provided [3] - A webcast of the call will be available on the company's website, along with a presentation and recent announcements [4] Group 2: Company Overview - Aemetis is headquartered in Cupertino, California, and focuses on renewable natural gas and renewable fuel technologies [5] - The company operates a biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas [5] - Aemetis owns a 65 million gallon per year ethanol production facility in California and an 80 million gallon per year biodiesel production facility in India [5] - The company is also developing sustainable aviation fuel and renewable diesel fuel biorefineries, along with renewable hydrogen and hydroelectric power projects [5]

I'm an avid investor with a long-term, and sometimes contrarian, approach to equities investing. I started out as a Tech analyst but now also cover Commodities and Energy sectors as the world navigates the energy transition. Analyst's Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it ( ...

Core Insights - Aemetis, Inc. announced the appointment of Anjaneyulu Ganji as Chief Financial Officer of its India subsidiary, Universal Biofuels, effective July 17, 2025 [1][2] Company Overview - Aemetis is a renewable natural gas and biofuels company focused on innovative technologies that lower fuel costs and reduce emissions [5] - The company operates a biogas digester network and pipeline system in California, converting dairy waste gas into Renewable Natural Gas [5] - Aemetis owns and operates an 80 million gallon per year biodiesel production facility in India and a 65 million gallon per year ethanol production facility in California [5] Leadership and Strategy - Anjaneyulu Ganji has extensive experience in finance, having previously served as Group CFO for Dodla Dairy Limited, which has an annual revenue of $450 million [2][3] - Ganji's background includes leadership roles in Marengo Asia Healthcare and Maersk Line, managing significant financial operations [3] - The leadership team at Aemetis is recognized for its ability to manage opportunities in India and has built a strong reputation in biofuel product delivery and quality [2] Market Context - The growing Indian economy is driving increased demand for energy sources such as biodiesel, ethanol, and compressed natural gas [2] - Universal Biofuels is expanding its production capabilities and diversifying into ethanol and renewable natural gas production [4]

Core Insights - Aemetis, Inc. will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York City from September 8-10, 2025, highlighting its focus on renewable natural gas and biofuels [1][2] - The biogas and biofuels sectors are expected to benefit from recent federal policies, including the One Big Beautiful Bill and proposed increases in Renewable Volume Obligation mandates by the EPA [3] - Aemetis is positioned as a diversified investment in multiple sectors, with significant projects in renewable natural gas production, ethanol, and carbon sequestration [3] Company Overview - Aemetis is headquartered in Cupertino, California, and focuses on renewable natural gas and biofuels, operating a biogas digester network and pipeline system to convert dairy waste into Renewable Natural Gas [4] - The company operates a 65 million gallon per year ethanol production facility in California and an 80 million gallon per year biodiesel production facility in India [4] - Aemetis is developing a carbon sequestration project and a renewable diesel fuel and SAF biorefinery in Riverbank, California [4] Project Highlights - Aemetis plans to expand its dairy renewable natural gas production to generate over 1 million MMBtu from 50 dairies [3] - The Keyes ethanol plant is expected to generate an additional $32 million in annual cash flow starting in 2026 due to a mechanical vapor recompression system [3] - The Riverbank carbon sequestration project aims to inject 1.4 million tons of CO2 underground annually [3]